Literature DB >> 19653300

Proligands with protease-regulated binding activity identified from cell-displayed prodomain libraries.

Jerry M Thomas1, Patrick S Daugherty.   

Abstract

A general method was developed for the discovery of protease-activated binding ligands, or proligands, from combinatorial prodomain libraries displayed on the surface of E. coli. Peptide libraries of candidate prodomains were fused with a matrix metalloprotease-2 substrate linker to a vascular endothelial growth factor-binding peptide and sorted using a two-stage flow cytometry screening procedure to isolate proligands that required protease treatment for binding activity. Prodomains that imparted protease-mediated switching activity were identified after three sorting cycles using two unique library design strategies. The best performing proligand exhibited a 100-fold improvement in apparent binding affinity after exposure to protease. This method may prove useful for developing therapeutic and diagnostic ligands with improved systemic targeting specificity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653300      PMCID: PMC2786969          DOI: 10.1002/pro.217

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  21 in total

1.  Reprogramming control of an allosteric signaling switch through modular recombination.

Authors:  John E Dueber; Brian J Yeh; Kayam Chak; Wendell A Lim
Journal:  Science       Date:  2003-09-26       Impact factor: 47.728

Review 2.  Rewiring cell signaling: the logic and plasticity of eukaryotic protein circuitry.

Authors:  John E Dueber; Brian J Yeh; Roby P Bhattacharyya; Wendell A Lim
Journal:  Curr Opin Struct Biol       Date:  2004-12       Impact factor: 6.809

Review 3.  The plasminogen-plasmin system.

Authors:  J Henkin; P Marcotte; H C Yang
Journal:  Prog Cardiovasc Dis       Date:  1991 Sep-Oct       Impact factor: 8.194

4.  A plausible mechanism for prothrombin activation by factor Xa, factor Va, phospholipid, and calcium ions.

Authors:  C T Esmon; W G Owen; C M Jackson
Journal:  J Biol Chem       Date:  1974-12-25       Impact factor: 5.157

5.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

Review 6.  Tumor-activated prodrugs--a new approach to cancer therapy.

Authors:  William A Denny
Journal:  Cancer Invest       Date:  2004       Impact factor: 2.176

7.  Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network.

Authors:  Tiebang Kang; Hideaki Nagase; Duanqing Pei
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

Review 8.  (Pro)Insulin processing: a historical perspective.

Authors:  Howard W Davidson
Journal:  Cell Biochem Biophys       Date:  2004       Impact factor: 2.194

9.  Creation of an allosteric enzyme by domain insertion.

Authors:  Gurkan Guntas; Marc Ostermeier
Journal:  J Mol Biol       Date:  2004-02-06       Impact factor: 5.469

10.  Directed evolution of a biterminal bacterial display scaffold enhances the display of diverse peptides.

Authors:  Jeffrey J Rice; Patrick S Daugherty
Journal:  Protein Eng Des Sel       Date:  2008-05-13       Impact factor: 1.650

View more
  6 in total

1.  Getting physical to fix pharma.

Authors:  Patrick R Connelly; T Minh Vuong; Mark A Murcko
Journal:  Nat Chem       Date:  2011-08-23       Impact factor: 24.427

2.  Screening of peptide libraries against protective antigen of Bacillus anthracis in a disposable microfluidic cartridge.

Authors:  Joshua M Kogot; Yanting Zhang; Stephen J Moore; Paul Pagano; Dimitra N Stratis-Cullum; David Chang-Yen; Marek Turewicz; Paul M Pellegrino; Andre de Fusco; H Tom Soh; Nancy E Stagliano
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

3.  Selective antibody activation through protease-activated pro-antibodies that mask binding sites with inhibitory domains.

Authors:  I-Ju Chen; Chih-Hung Chuang; Yuan-Chin Hsieh; Yun-Chi Lu; Wen-Wei Lin; Chien-Chiao Huang; Ta-Chun Cheng; Yi-An Cheng; Kai-Wen Cheng; Yeng-Tseng Wang; Fang-Ming Chen; Tian-Lu Cheng; Shey-Cherng Tzou
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

4.  FimH as a scaffold for regulated molecular recognition.

Authors:  Shivani Gupta Ludwig; Casey L Kiyohara; Laura A Carlucci; Dagmara Kisiela; Evgeni V Sokurenko; Wendy Evelyn Thomas
Journal:  J Biol Eng       Date:  2021-01-12       Impact factor: 6.248

5.  Switchable immune modulator for tumor-specific activation of anticancer immunity.

Authors:  Yu Zhao; Yu-Qing Xie; Simon Van Herck; Sina Nassiri; Min Gao; Yugang Guo; Li Tang
Journal:  Sci Adv       Date:  2021-09-10       Impact factor: 14.136

Review 6.  Exploiting protease activation for therapy.

Authors:  Chloe Bleuez; Wolfgang F Koch; Carole Urbach; Florian Hollfelder; Lutz Jermutus
Journal:  Drug Discov Today       Date:  2022-03-18       Impact factor: 8.369

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.